Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Enasidenib Drives Maturation of Human Erythroid Precursors Independently of IDH2

Ritika Dutta, BS, Tian Y Zhang, MD PhD, Thomas Koehnke, MD, Daniel Thomas, MD PhD, Eric Gars, MD, Melissa Stafford, Yusuke Nakauchi, MD PhD, Satinder Kaur, BS, Raymond Yin, Anupama Narla, MD, Ravindra Majeti, MD PhD

Blood (2019) 134 (Supplement_1): 540.

https://doi.org/10.1182/blood-2019-124551

Published: 2019

Journal Articles

99m. Tc-Rituximab as Radiotracer For Molecular Imaging In Non Hodgkin Lymphoma

Ximena Camacho, MSc, Agustina Banchero, MD, Maria Fernanda García, MSc, Marcelo Fernández, BSc, Natalia Oddone, BSc, María Moreno, PhD, Cecilia Guillermo, MD, Juan Pablo Gambini, MD, PhD, Pablo Cabral, MSc, PhD, Eloísa Riva, MD

Blood (2013) 122 (21): 3026.

https://doi.org/10.1182/blood.V122.21.3026.3026

Published: 2013

Journal Articles

Flow Cytometry Thresholds of Myeloperoxidase Detection to Discriminate Between Acute Lymphoblastic or Myeloblastic Leukemia

Julien Guy, Iléana Antony-Debré, Isabelle Arnoux, Chantal Fossat, Emmanuel Benayoun, Magali Le Garff-Tavernier, Anna Raimbault, Michèle Imbert, MD, Marc Maynadie, MD, PhD, Francis Lacombe, Marie C Béné, Orianne Wagner-Ballon

Blood (2012) 120 (21): 1450.

https://doi.org/10.1182/blood.V120.21.1450.1450

Published: 2012

Journal Articles

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

Blood (2012) 120 (21): 143.

https://doi.org/10.1182/blood.V120.21.143.143

Published: 2012

Journal Articles

A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)

Blood (2012) 120 (21): 3597.

https://doi.org/10.1182/blood.V120.21.3597.3597

Published: 2012

Journal Articles

Phospho-Specific Flow Cytometry of Fixed Whole Blood Demonstrates In Vivo FLT3 Inhibition in Circulating Leukemic Blasts During AC220 Therapy and Accurately Detects the Development of Therapeutic Resistance,

Alexander E Perl, MD, Grace R Jeschke, Catherine C. Smith, MD, James K. Mangan, MD, PhD, Selina M. Luger, MD, Martin Carroll, MD

Blood (2011) 118 (21): 3502.

https://doi.org/10.1182/blood.V118.21.3502.3502

Published: 2011

Journal Articles

Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein in AML Blasts During Trials Combining Sirolimus and Intensive Chemotherapy: Target Inhibition Enhances Response

Margaret Kasner, MD, Selina M. Luger, MD, Grace R Jeschke, Rosemarie Mick, MS, Martin Carroll, MD, Alexander E Perl, MD

Blood (2011) 118 (21): 230.

https://doi.org/10.1182/blood.V118.21.230.230

Published: 2011

Journal Articles

Phospho-Specific Flow Cytometry of Fixed Whole Blood During AML Clinical Trials to Monitor In Vivo FLT3 Inhibition in Leukemic Blasts,

Alexander E Perl, MD, Grace R Jeschke, Takashi Sato, Shiro Akinaga, Niranjan S. Rao, PhD, Maria R. Baer, MD, Mark J. Levis, MD, PhD, Martin Carroll, MD

Blood (2011) 118 (21): 3508.

https://doi.org/10.1182/blood.V118.21.3508.3508

Published: 2011

Journal Articles

High Throughput Screening Reveals Unique Sensitivity of CD34+CD38- AML Cells to Isotretinoin and Tretinoin

Wen Xie, MS, Duane C Hassane, PhD, Craig T. Jordan, PhD, Gail J. Roboz, MD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 1430.

https://doi.org/10.1182/blood.V118.21.1430.1430

Published: 2011

Journal Articles

Th17/IL-17 Might Play a Protective Role in CLL Immunity

Iwona Hus, Jacek M. Rolinski, Agnieszka ABJ Bojarska-Junak, Magdalena Gorska, Anna Dmoszynska

Blood (2011) 118 (21): 2843.

https://doi.org/10.1182/blood.V118.21.2843.2843

Published: 2011

Journal Articles

Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors

Maria Ida Bonetti, Laura Pieri, Lola Domenici, Serena Urbani, Giovanni Romano, Alessandra Aldinucci, Clara Ballerini, Monica Monici, Riccardo Saccardi, Venere Basile, Alberto Bosi, Paolo Romagnoli

Blood (2011) 117 (15): 3983–3995.

https://doi.org/10.1182/blood-2010-08-299735

Published: 2011

Journal Articles

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Ann Brinch Madelung, MD, Michael Bzorek, MT, Henrik Bondo, MD, Eva M.K. Zetterberg, MD, PhD, Ole Weis Bjerrum, MD, DMSc, Hans Carl Hasselbalch, MD, DMSc, Stefan Scheding, MD, Elisabeth Ralfkiaer, Prof., MD, DMSc

Blood (2010) 116 (21): 4108.

https://doi.org/10.1182/blood.V116.21.4108.4108

Published: 2010

Journal Articles

Three-Dimensional Visualization of Immunological Processes of Entire Organs in Subcellular Resolution.

Christian Brede, Mike Friedrich, Ana-Laura Jordán-Garrote, Simone S Riedel, Carina A Baeuerlein, Carolin Kiesel, Miriam Ritz, Marina Grether, Rossella Monteforte, PhD, Stephan Schulz, MD, Hermann Einsele, MD, Robert S Negrin, MD, Gregory S Harms, PhD, Andreas Beilhack, MD

Blood (2009) 114 (22): 61.

https://doi.org/10.1182/blood.V114.22.61.61

Published: 2009

Journal Articles

Discrimination and Quantification of Spectrally Similar Near-Infrared Probes by Time-Domain (TD) Optical Imaging in Acute Myeloid Leukemia Mouse Models.

Emmet McCormack, PhD, Alexandre Belankov, PhD, Maja Mujic, MSc, Pierre Couture, Bjorn T. Gjertsen, MD, PhD

Blood (2007) 110 (11): 4319.

https://doi.org/10.1182/blood.V110.11.4319.4319

Published: 2007

Journal Articles

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Cristina Rodriguez, MD, Tao Jin, MS, Rony Abou Jawde, MD, Wael Saber, MD, Rachid Baz, MD, Eric His, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Anjali Advani, MD

Blood (2006) 108 (11): 4510.

https://doi.org/10.1182/blood.V108.11.4510.4510

Published: 2006

Journal Articles

Dysregulation of Phosphatidylserine Scrambling by Oxidative Stress.

Kitty DeJong, PhD, Frans A. Kuypers, PhD

Blood (2006) 108 (11): 1573.

https://doi.org/10.1182/blood.V108.11.1573.1573

Published: 2006

Journal Articles

Reactive Oxygen Species and RBC Membrane Integrity in Peroxyredoxin II Deficient Mice.

Amrita Bhagat, Renee Emerson, Kitty DeJong, PhD, Frans A. Kuypers, PhD

Blood (2004) 104 (11): 54.

https://doi.org/10.1182/blood.V104.11.54.54

Published: 2004

Journal Articles

Visualizing Allogeneic Bone Marrow (BM) Graft Rejection.

Patricia Taylor, DVM, Angela Panoskaltsis-Mortari, PhD, Randolph Noelle, PhD, Alexander Rudensky, PhD, Jonathan Serody, MD, PhD, Bruce Blazar, MD

Blood (2004) 104 (11): 43.

https://doi.org/10.1182/blood.V104.11.43.43

Published: 2004

Journal Articles

Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization

Mahesh Choolani, Hilary O'Donnell, Cesare Campagnoli, Sailesh Kumar, Irene Roberts, Phillip R. Bennett, Nicholas M. Fisk

Blood (2001) 98 (3): 554–557.

https://doi.org/10.1182/blood.V98.3.554

Published: 2001

NARROW

Enasidenib Drives Maturation of Human Erythroid Precursors Independently of IDH2

99m. Tc-Rituximab as Radiotracer For Molecular Imaging In Non Hodgkin Lymphoma

Flow Cytometry Thresholds of Myeloperoxidase Detection to Discriminate Between Acute Lymphoblastic or Myeloblastic Leukemia

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)

Phospho-Specific Flow Cytometry of Fixed Whole Blood Demonstrates In Vivo FLT3 Inhibition in Circulating Leukemic Blasts During AC220 Therapy and Accurately Detects the Development of Therapeutic Resistance,

Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein in AML Blasts During Trials Combining Sirolimus and Intensive Chemotherapy: Target Inhibition Enhances Response

Phospho-Specific Flow Cytometry of Fixed Whole Blood During AML Clinical Trials to Monitor In Vivo FLT3 Inhibition in Leukemic Blasts,

High Throughput Screening Reveals Unique Sensitivity of CD34+CD38- AML Cells to Isotretinoin and Tretinoin

Th17/IL-17 Might Play a Protective Role in CLL Immunity

Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Three-Dimensional Visualization of Immunological Processes of Entire Organs in Subcellular Resolution.

Discrimination and Quantification of Spectrally Similar Near-Infrared Probes by Time-Domain (TD) Optical Imaging in Acute Myeloid Leukemia Mouse Models.

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Dysregulation of Phosphatidylserine Scrambling by Oxidative Stress.

Reactive Oxygen Species and RBC Membrane Integrity in Peroxyredoxin II Deficient Mice.

Visualizing Allogeneic Bone Marrow (BM) Graft Rejection.

Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only